Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Agouron files first NDA submission

Dec. 24, 1996

Novel anti-HIV agent from NCI

Dec. 24, 1996

NanoSystems to develop novel formulation of HIV protease inhibitor

Dec. 23, 1996

IND filed for Cytel HIV therapeutic vaccine

Dec. 23, 1996

The role of host factors in HIV pathogenesis

Dec. 19, 1996

HemispheRx and Temple University enter new agreement for Oragen products

Dec. 19, 1996

MRC offers Fv1 gene for licensing

Dec. 17, 1996

New HIV-1 protease inhibitor in development at LG Chemical

Dec. 13, 1996

Procept's topical microbicide enters phase I in Europe

Dec. 12, 1996

Italian researchers described novel anti-HIV compounds

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...